Evaluation of the seventh edition of the tumour, node, metastasis (TNM) classification for colon cancer in two nationwide registries of the United States and Japan

Colorectal Disease

Volumn 14, Issue 9, 2012, Pages 1065-1074

  Hashiguchi, Y ^a   Hase, K ^a   Kotake, K ^b   Ueno, H ^a   Shinto, E ^a   Mochizuki, H ^a   Yamamoto, J ^a   Sugihara, K ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOCHIGI CANCER CENTER   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Colon cancer; SEER; TNM

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; COLON CANCER; FEMALE; HUMAN; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; UNITED STATES;

AGED; COLONIC NEOPLASMS; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 84865417194     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2011.02917.x     Document Type: Article

References (22)

1. Sobin LH, Gospodarowicz MK, Wittekind CH. (2010 7th edition) International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. John Wiley & Sons Ltd, Oxford.
2. Mori T. A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer. Cancer Invest 2010; 28: 387-92.
3. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28: 264-71.
4. Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin 2008; 58: 180-90.
5. Sakamoto J, Ohashi Y, Hamada C, Buyse M, Burzykowski T, Piedbois P. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 2004; 22: 484-92.
6. Andre T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-16.
7. Coleman MP, Quaresma M, Berrino F et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-56.
8. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006; 24: 3570-5.
9. Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 2010; 53: 65-70.
10. Kotake K, Honjo S, Sugihara K et al. Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 2003; 46: S32-43.
11. Ajiki W, Kinoshita N, Tsukuma H, Oshima A. Cancer incidence and incidence rates in Japan in 1996: estimates based on data from 10 population-based cancer registries. Jpn J Clin Oncol 2001; 31: 410-4.
12. Kusters M, Beets GL, van de Velde CJ et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 2009; 249: 229-35.
13. Sobin LH, Wittekind CH. (2002 6th edition) International Union Against Cancer (UICC). TNM classification of malignant tumours. Wiley-Liss Publications, New York, NY, USA.
14. Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12: 309-20.
15. Japanese Society for Cancer of the Colon and Rectum (2009 2nd English edition). Japanese Classification of Colorectal Carcinoma. Kanehara &Co., Ltd., Tokyo.
16. Ueno S, Tanabe G, Sako K et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 529-34.
17. Tateishi R, Yoshida H, Shiina S et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 2005; 54: 419-25.
18. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.
19. Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst 2009; 101: 878-87.
20. Kim KH, Yang SS, Yoon YS, Lim SB, Yu CS, Kim JC. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea. Colorectal Dis 2011; 14: e220-6.
21. Cho YK, Chung JW, Kim JK et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer 2008; 112: 352-61.
22. Ueno H, Mochizuki H, Shirouzu K et al. Actual status of distribution and prognostic impact of extramural discontinuous cancer spread in colorectal cancer. J Clin Oncol 2011; 29: 2550-6.